Summary
This 8-K filing from Amgen Inc. (AMGN) on August 13, 2002, primarily serves to announce the public filing of its Quarterly Report on Form 10-Q for the period ending June 30, 2002. This filing is significant as it marks Amgen's compliance with the new certification requirements mandated by Section 906 of the Sarbanes-Oxley Act of 2002, which became effective earlier that year. Investors can find detailed financial and operational information for the second quarter of 2002 within the accompanying Form 10-Q. The inclusion of the Section 906 certifications underscores Amgen's commitment to enhanced corporate governance and financial transparency. While this 8-K itself does not contain new operational or financial performance data beyond what is presented in the 10-Q, it is a crucial regulatory disclosure indicating the timely submission of the company's quarterly financial statements and the CEO's and CFO's certifications regarding their accuracy and completeness.
Key Highlights
- 1Amgen Inc. filed its Quarterly Report on Form 10-Q for the period ended June 30, 2002.
- 2The filing was made on August 13, 2002.
- 3This 8-K includes the required certifications under Section 906 of the Sarbanes-Oxley Act of 2002.
- 4These certifications are provided by Amgen's principal executive and financial officers.
- 5The report signals compliance with new regulatory requirements for financial disclosures.
- 6No new material financial or operational information is presented in this 8-K itself, but it directs investors to the 10-Q for detailed quarterly results.